<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent studies have suggested that a novel adipokine, C1q/<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-related protein-3 (CTRP-3), a paralog of adiponectin, may play an important role in the regulation of <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism and innate immunity </plain></SENT>
<SENT sid="1" pm="."><plain>Pigment epithelium-derived factor (PEDF), a multifunctional protein with <z:chebi fb="11" ids="22586">antioxidant</z:chebi> and anti-inflammatory properties, is associated with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We examined circulating CTRP-3 and PEDF concentrations in 345 subjects with diverse <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance statuses </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, we evaluated the involvement of CTRP-3 and PEDF with cardiometabolic risk factors including <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, high-sensitivity C-reactive protein (hsCRP), estimated glomerular filtration rate (eGFR), and brachial-ankle pulse wave velocity (baPWV) </plain></SENT>
<SENT sid="4" pm="."><plain>CTRP-3 concentrations were significantly higher in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> than the <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance group, whereas PEDF levels were not different </plain></SENT>
<SENT sid="5" pm="."><plain>Subjects with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> showed significantly higher levels of both CTRP-3 and PEDF compared with subjects without <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Both CTRP-3 and PEDF were significantly associated with cardiometabolic parameters, including waist-to-hip ratio, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi>, alanine aminotransferase, eGFR, hsCRP, and baPWV </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, circulating CTRP-3 concentrations were elevated in patients with <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism dysregulation </plain></SENT>
<SENT sid="8" pm="."><plain>Both CTRP-3 and PEDF concentrations were increased in subjects with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and associated with various cardiometabolic risk factors </plain></SENT>
</text></document>